{"id":390949,"date":"2017-07-11T00:00:00","date_gmt":"2017-07-11T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/algoim0039-2017-biopharma-psoriatic-arthritis-treatment-algorithms-claims-data-analysis-us-2017\/"},"modified":"2026-05-01T11:42:29","modified_gmt":"2026-05-01T11:42:29","slug":"algoim0039-2017-biopharma-psoriatic-arthritis-treatment-algorithms-claims-data-analysis-us-2017","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/algoim0039-2017-biopharma-psoriatic-arthritis-treatment-algorithms-claims-data-analysis-us-2017\/","title":{"rendered":"Psoriatic Arthritis | Treatment Algorithms: Claims Data Analysis | US | 2017"},"content":{"rendered":"<p>The algorithms for treating psoriatic arthritis ( PsA ) are unique among rheumatic diseases because most PsA patients receive prior treatment by dermatologists for psoriasis, with many of the same therapies that are frequently used for PsA . Therefore, biologic and targeted synthetic DMARD s are more frequently used as early-line therapies after the diagnosis of PsA . Understanding the use of non- TNF inhibitors, namely, IL -12\/23 inhibitors, IL -17 inhibitors, and PDE -4 inhibitors, is crucial for pharmaceutical companies to properly manage their brands in the PsA market. Claims data analysis provides an objective lens to see how physicians prescribe therapies and reveals real-world data on persistency and compliance of the PsA therapies.<\/p>\n","protected":false},"template":"","class_list":["post-390949","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-psoriatic-arthritis","biopharma-product-treatment-algorithms-claims-data-analysis","biopharma-geography-us","biopharma-date-890"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390949","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390949\/revisions"}],"predecessor-version":[{"id":394073,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390949\/revisions\/394073"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=390949"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}